HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Left ventricular thrombus — Clinical Guidelines

Overview

Left ventricular thrombus (LVT) is a complication associated with systolic dysfunction, increasing the risk of stroke and systemic embolism. Traditionally managed with warfarin, the efficacy and safety of direct oral anticoagulants (DOACs) are increasingly being evaluated.

Diagnosis

Echocardiography: Primary imaging modality for detection 1 13 22.

Transesophageal Echocardiography (TEE): Provides detailed visualization, especially useful for small or difficult-to-detect thrombi 1 13.

Spectral CT Dual-Substance Separation Technology: Valuable for diagnosing LVT when echocardiography is inconclusive 10.

Indium-111 Platelet Scintigraphy: Useful adjunct for detecting thrombi, influenced by clot size and age 23 27.

Management

First-Line Treatment:

- Warfarin: Historically standard of care 1 2 4. - Direct Oral Anticoagulants (DOACs): Emerging as alternatives, with reduced-dose apixaban showing efficacy in case reports 4 5 6 7.

Adjunctive Treatments:

- High-Dose Intravenous Heparin: Effective for high embolic risk thrombi 18. - Specific Agents: Lepirudin successfully resolved thrombus in one case after heparin failure 11.

Special Populations

Comorbidities: Hypercoagulable states (e.g., polycystic disease) may necessitate tailored anticoagulation 26.

Elderly: Management considerations similar to general population, but careful monitoring of drug interactions and renal function is crucial [Evidence: Expert opinion].

Key Recommendations

Primary Anticoagulation Therapy: Warfarin remains a standard option, but DOACs are increasingly supported as effective alternatives 1 5 7 (Evidence: Moderate).

Monitoring and Follow-Up: Regular echocardiographic monitoring is essential to assess thrombus resolution and detect embolic risk 1 19 (Evidence: Moderate).

High Embolic Risk: Consider high-dose intravenous heparin for patients with mobile or protruding thrombi 18 (Evidence: Weak).

Novel Therapies: Case reports suggest potential for lepirudin in refractory cases, warranting further investigation 11 (Evidence: Weak).

References

1 Hillis GS, Walker JSK, Gilbert T, Budgeon CA, French JK, Selvanayagam JB et al.. Rationale for and design of the REsolution of LEft VENTricular thrombus (RELEVENT) Trial. American heart journal 2026. link 2 Al-Abcha A, Clay S, Wang L, Prasad RM, Salam MF, Srivastava S et al.. Direct Oral Anticoagulants Versus Warfarin for the Treatment of Left Ventricular Thrombus: A Multicenter Retrospective Observational Study. The American journal of cardiology 2025. link 3 Yao Z, Gue Y, Lip GYH. Comparison of Direct Oral Anticoagulants and Vitamin K Antagonists for Left Ventricular Thrombus: A Global Retrospective Study. The American journal of medicine 2025. link 4 Bundrick AE, Bowers RD, Perkins SL, Baker CN. Reduced-Dose Apixaban in the Treatment of Left Ventricular Thrombus: A Report of 2 Cases. Journal of pharmacy practice 2024. link 5 Willeford A, Zhu W, Stevens C, Thomas IC. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Left Ventricular Thrombus. The Annals of pharmacotherapy 2021. link 6 Cochran JM, Jia X, Kaczmarek J, Staggers KA, Rifai MA, Hamzeh IR et al.. Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: A Retrospective, Multicenter Study and Meta-Analysis of Existing Data. Journal of cardiovascular pharmacology and therapeutics 2021. link 7 Al-Abcha A, Herzallah K, Saleh Y, Mujer M, Abdelkarim O, Abdelnabi M et al.. The Role of Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi: A Meta-Analysis and Systematic Review. American journal of cardiovascular drugs : drugs, devices, and other interventions 2021. link 8 Harfi TT, Seo JH, Yasir HS, Welsh N, Mayer SA, Abraham TP et al.. The E-wave propagation index (EPI): A novel echocardiographic parameter for prediction of left ventricular thrombus. Derivation from computational fluid dynamic modeling and validation on human subjects. International journal of cardiology 2017. link 9 Gerstein NS, Brierley JK, Culling MD. Left ventricle thrombus after tranexamic acid for spine surgery in an HIV-positive patient. The spine journal : official journal of the North American Spine Society 2016. link 10 Zeng H, Zhang MC, He YQ, Liu L, Tong YL, Yang P. Application of spectral computed tomography dual-substance separation technology for diagnosing left ventricular thrombus. The Journal of international medical research 2016. link 11 Margulescu AD, Fraser AG. Resolution of left ventricular thrombus with lepirudin after failed treatment with heparin. The American journal of emergency medicine 2012. link 12 Calleja AC, Alharthi MS, Khandheria BK, Chaliki HP. Contrast-enhanced right atrial mass: tumour or thrombus?. European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2009. link 13 Sinha A, Nanda NC, Khanna D, Dod HS, Vengala S, Mehmood F et al.. Morphological assessment of left ventricular thrombus by live three-dimensional transthoracic echocardiography. Echocardiography (Mount Kisco, N.Y.) 2004. link 14 Mathieu P, Marchand R, Tardif J, Perrault LP. Ventriculotomy and resection for left ventricular thrombus infection with Salmonella. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2000. link00491-7) 15 Bach DS. Adherence of albunex to an apical left ventricular thrombus. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 1999. link70027-1) 16 Carpenter K, Adams D. Apical mural thrombus: technical pitfalls. Heart (British Cardiac Society) 1998. link 17 Misumi I, Kimura Y, Hokamura Y, Honda Y, Misumi K, Nishimura K et al.. Predicting risk of embolization during anticoagulation for left atrial thrombus by transesophageal echocardiography: a case report. Journal of cardiology 1996. link 18 Heik SC, Kupper W, Hamm C, Bleifeld W, Koschyk DH, Waters D et al.. Efficacy of high dose intravenous heparin for treatment of left ventricular thrombi with high embolic risk. Journal of the American College of Cardiology 1994. link90113-9) 19 Lee KS, Lever HM. The role of echocardiography in assessing the morphological response of left ventricular thrombus to anticoagulation. Echocardiography (Mount Kisco, N.Y.) 1994. link 20 Brickner ME, Friedman DB, Cigarroa CG, Grayburn PA. Relation of thrombus in the left atrial appendage by transesophageal echocardiography to clinical risk factors for thrombus formation. The American journal of cardiology 1994. link90409-x) 21 Kwan T, Feit A. Late neovascularization of longstanding left ventricular mural thrombus--a case report. Angiology 1993. link 22 Vaganos SA, Fox KR, Kitchen JG. Left ventricular thrombus in the absence of detectable heart disease. Chest 1989. link 23 Seabold JE, Schröder E, Conrad GR, Ponto J, Bruch P, Petersen D et al.. Indium-111 platelet scintigraphy and two-dimensional echocardiography for detection of left ventricular thrombus: influence of clot size and age. Journal of the American College of Cardiology 1987. link80308-x) 24 Rousso I, Deviri E, Lerner MA, Jortner R, Levy MJ. CT diagnosis of left atrial thrombus undiagnosed by echocardiography. Computerized radiology : official journal of the Computerized Tomography Society 1984. link90041-6) 25 Stratton JR, Ritchie JL. The effects of antithrombotic drugs in patients with left ventricular thrombi: assessment with indium-111 platelet imaging and two-dimensional echocardiography. Circulation 1984. link 26 Schmaier AH, Denenberg B. Left ventricular thrombus with normal left ventricular function and hyperaggregable platelets in a patient with polycystic disease of multiple organs. The American journal of the medical sciences 1984. link 27 Ezekowitz MD, Burrow RD, Heath PW, Streitz T, Smith EO, Parker DE. Diagnostic accuracy of indium-111 platelet scintigraphy in identifying left ventricular thrombi. The American journal of cardiology 1983. link90216-3) 28 Cullen JG, Korcuska K, Musser G, Schiller NB, Clark RD. Calcified left ventricular thrombus causing repeated retinal arterial emboli: clinical, echocardiographic, and pathologic features. Chest 1981. link 29 Gallo JI, Ruiz B, Duran CM. A safe technique for removal of massive left atrial thrombus. The Annals of thoracic surgery 1981. link60945-9) 30 Sunagawa K, Orita Y, Tanaka S, Kikuchi Y, Nakamura M, Hirata T. Left atrial ball thrombus diagnosed by two-dimensional echocardiography. American heart journal 1980. link90283-5) 31 Calick A, Dorsey TJ. Neovascularity related to a mural thrombus. Catheterization and cardiovascular diagnosis 1979. link 32 DeJoseph RL, Shiroff RA, Levenson LW, Martin CE, Zelis RF. Echocardiographic diagnosis of intraventricular clot. Chest 1977. link 33 Standen JR. "Tumor vascularity" in left atrial thrombus demonstrated by selective coronary arteriography. Radiology 1975. link 34 Goolsby J, Steele P, Kirch D, Battock D, Davies H. The square left ventricle: an angiographic and radionuclide sign of left ventricular thrombus. Radiology 1975. link

Left ventricular thrombus